Suppr超能文献

缺失的环节(er):药物发现中大环化的路线图。

The Missing Link(er): A Roadmap to Macrocyclization in Drug Discovery.

机构信息

Department of Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University of Darmstadt, 64287 Darmstadt, Germany.

Centre for Synthetic Biology, Technical University of Darmstadt, 64287 Darmstadt, Germany.

出版信息

J Med Chem. 2024 Sep 12;67(17):14768-14785. doi: 10.1021/acs.jmedchem.4c01163. Epub 2024 Aug 22.

Abstract

Macrocycles are one of nature's preferred choices to generate large but cell-permeable bioactive molecules. Macrocyclization is increasingly prominent in medicinal chemistry beyond natural products, especially for difficult-to-drug targets. However, strategies to best exploit the potential of macrocycles are only beginning to emerge. Here we survey drug discovery campaigns from the past decade that cumulated in advanced macrocyclic drug-like compounds or drug candidates. Most macrocycles were conceived by ring closing based on U- or C-shaped bioactive conformations observed in co-crystal structures. We focus on the key step from linear precursors to the first macrocycle and the follow-up optimization of the resulting macrocyclic scaffold. Conformational control recurrently emerged as a key factor for macrocycle properties and linkers as an opportunity for optimization. With increasingly challenging drug targets, we expect these trends to become more prominent and relevant.

摘要

大环化合物是自然界生成大型但可穿透细胞的生物活性分子的首选之一。除了天然产物外,大环化在药物化学中越来越受到重视,尤其是对于难以成药的靶点。然而,充分发挥大环化合物潜力的策略才刚刚开始出现。在这里,我们调查了过去十年中积累了先进大环类似物药物或候选药物的药物发现项目。大多数大环化合物是通过基于共晶结构中观察到的 U 形或 C 形生物活性构象的环合反应构思出来的。我们重点介绍从线性前体到第一个大环化合物的关键步骤,以及随后对所得大环骨架的优化。构象控制经常成为大环化合物性质的关键因素,连接子则是优化的机会。随着越来越具有挑战性的药物靶点,我们预计这些趋势将变得更加突出和相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验